These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 14690339

  • 1. Scalp psoriasis: synergy between the Malassezia yeasts and skin irritation due to calcipotriol.
    Faergemann J, Diehl U, Bergfelt L, Brodd A, Edmar B, Hersle K, Lindemalm B, Nordin P, Ringdahl IR, Serup J.
    Acta Derm Venereol; 2003; 83(6):438-41. PubMed ID: 14690339
    [Abstract] [Full Text] [Related]

  • 2. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C, Hoffmann V, Shapiro J, Saari S, Cambazard F, Milsgaard M.
    Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S.
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [Abstract] [Full Text] [Related]

  • 4. Long-term treatment of psoriasis with calcipotriol scalp solution and cream.
    Barnes L, Altmeyer P, Fôrstrôm L, Stenström MH.
    Eur J Dermatol; 2000 Jul; 10(3):199-204. PubMed ID: 10725818
    [Abstract] [Full Text] [Related]

  • 5. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP, Ganslandt C, Tan J, Nordin P, Kragballe K, Segaert S.
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [Abstract] [Full Text] [Related]

  • 6. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC, Hoffmann V, Anstey A, Barnes L, Bolduc C, Reich K, Saari S, Segaert S, Vaillant L.
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [Abstract] [Full Text] [Related]

  • 7. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
    Duweb GA, Abuzariba O, Rahim M, al-Taweel M, Abdulla SA.
    Int J Clin Pharmacol Res; 2000 Jan; 20(3-4):65-8. PubMed ID: 11314240
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [Abstract] [Full Text] [Related]

  • 9. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.
    Reygagne P, Mrowietz U, Decroix J, de Waard-van der Spek FB, Acebes LO, Figueiredo A, Caputo R, Poncet M, Arsonnaud S.
    J Dermatolog Treat; 2005 Feb; 16(1):31-6. PubMed ID: 15897165
    [Abstract] [Full Text] [Related]

  • 10. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC, van der Valk PG, Swinkels OQ, Kucharekova M, de Rie MA, de Vries HJ, Damstra R, Oranje AP, de Waard-van der Spek FB, van Neer P, Lijnen RL, Kunkeler AC, van Hees C, Haertlein NG, Hol CW.
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [Abstract] [Full Text] [Related]

  • 11. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
    Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Jolliffe D, Peyri J, Svensson A, Toole J, Wozel G.
    Br J Dermatol; 2006 Jun; 154(6):1155-60. PubMed ID: 16704648
    [Abstract] [Full Text] [Related]

  • 12. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis.
    Poulin Y, Papp K, Bissonnette R, Barber K, Kerrouche N, Villemagne H, Calepso Study Team.
    J Dermatolog Treat; 2010 May; 21(3):185-92. PubMed ID: 20131980
    [Abstract] [Full Text] [Related]

  • 13. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB, Ganslandt C, Ortonne JP, Poulin Y, Burden AD, de Unamuno P, Berne B, Figueiredo A, Austad J.
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [Abstract] [Full Text] [Related]

  • 14. Calcipotriol solution in scalp psoriasis.
    Duweb G, Alhaddar J, Abuhamida M.
    Int J Tissue React; 2005 Sep; 27(4):163-6. PubMed ID: 16440580
    [Abstract] [Full Text] [Related]

  • 15. Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.
    Ma L, Yang Q, Yang H, Wang G, Zheng M, Hao F, Gu J, Sun Q, Cui P, Ge M, Li R, Gao T, Facy P, Kurvits M, Xu Z, Xu J.
    Int J Dermatol; 2016 Jan; 55(1):106-13. PubMed ID: 26094549
    [Abstract] [Full Text] [Related]

  • 16. The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
    Freeman K.
    Curr Med Res Opin; 2011 Jan; 27(1):197-203. PubMed ID: 21142834
    [Abstract] [Full Text] [Related]

  • 17. Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.
    Affleck AG, Bottomley JM, Auland M, Jackson P, Ryttov J.
    Curr Med Res Opin; 2011 Jan; 27(1):269-84. PubMed ID: 21142836
    [Abstract] [Full Text] [Related]

  • 18. Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis.
    Tzung TY, Wu JC, Hsu NJ, Chen YH, Ger LP.
    Acta Derm Venereol; 2005 Jan; 85(3):236-9. PubMed ID: 16040409
    [Abstract] [Full Text] [Related]

  • 19. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G, Aldebani S, Elzorghany A, Benghazil M, Alhaddar J.
    Int J Clin Pharmacol Res; 2003 Jan; 23(2-3):47-51. PubMed ID: 15018018
    [Abstract] [Full Text] [Related]

  • 20. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
    Guenther LC.
    Skin Therapy Lett; 2009 May; 14(4):1-4. PubMed ID: 19585059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.